Anavex Life Sciences Corp (AVXL)

[F1ash]

Someone on here stated that if poor results were known the company legally was forced to reveal them.
Anyone know what the reality is there? Thanks

For most practical purposes, the reality is, they don't have to tell investors about "poor results". If, for instance, patients began dying and the FDA placed a clinical hold on the trial, then the company would have to notify investors in that case.

Otherwise, typically, "poor data" doesn't have to be disseminated until trial completion. As an example, did Anavex notify investors each time a trial participant dropped out?